Latest News - Zimmer Biomet
Top Corporates Hub
Zimmer Biomet
Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know
10.04.2026 10:34
Zimmer Biomet is poised to report its first-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
09.04.2026 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
Zimmer Biomet (ZBH) Valuation Check After New Technology Leadership And Robotic Shoulder Surgery Milestones
09.04.2026 06:09
Zimmer Biomet Holdings (ZBH) is back in focus after two technology linked milestones: the appointment of a new chief science and technology leader and a high profile robotic assisted shoulder surgery using its ROSA platform in an outpatient setting. See our latest analysis for Zimmer Biomet Holdings. Despite the recent headlines around robotics and leadership changes, momentum in Zimmer Biomet’s shares has been subdued, with a 1-week share price return of 2.2% and a 1-year total shareholder...
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Split On Growth And Execution
28.03.2026 00:15
Zimmer Biomet Holdings has seen only a modest tweak to its fair value estimate, shifting from US$102.65 to US$103.00, which keeps the core valuation story largely intact. That kind of incremental change lines up with mixed Street commentary, where some analysts are nudging targets higher while others are cutting or stepping back on concerns around growth consistency and execution. As you read on, you will see how these competing views shape the evolving narrative and what to watch if you are...
Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026
27.03.2026 00:30
Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, today announced it received three awards at the Healthcare Asia Medtech Awards 2026, recognizing the company's innovations across orthopedic product development, digital health and surgeon engagement.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
25.03.2026 12:21
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
BTIG downgrades Zimmer Biomet, sees limited upside amid growth challenges
23.03.2026 16:15
Investing.com -- BTIG downgraded Zimmer Biomet Holdings to Neutral from Buy, citing weak growth momentum and limited catalysts to drive shares higher in the near term.
Integral Molecular Appoints Cheryl Paes as Vice President of Commercial Strategy
23.03.2026 13:55
Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces that Cheryl Paes has joined the company as Vice President of Commercial Strategy. In this role, Paes will lead strategic initiatives to support the continued commercial growth of the company's technology platforms to serve the biotechnology and pharmaceutical industries.
Zimmer Biomet: Down On Its Knees, Shares Look Appealing
23.03.2026 13:27
Zimmer Biometâs stock is a "Buy" given its sales growth and outlook. Here's what investors need to know.
BTIG Downgrades Zimmer Biomet Holdings to Neutral
23.03.2026 05:40
BTIG analyst Ryan Zimmerman downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Buy to Neutral.
Surgical Equipment & Consumables - Diversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers
19.03.2026 11:05
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Zimmer Biomet (NYSE:ZBH).
ISRG's da Vinci Gains FDA Nod for Cardiac Surgery: TAM Growth Ahead?
12.03.2026 16:18
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.
Why Is Zimmer (ZBH) Down 2% Since Last Earnings Report?
12.03.2026 15:30
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins
26.02.2026 05:09
Zimmer Biomet Holdings has seen its modeled fair value price target nudged from $102.96 to $102.65, signaling only a very small adjustment in the underlying valuation work. That slight trim comes as analysts remain split, with some highlighting potential upside if execution improves and others pointing to continued questions around growth and margins. As you read on, you will see how these differing views, and any further price target moves, can help you track the evolving story around the...
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
25.02.2026 12:06
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it will unveil new clinical and operational data and showcase its newest innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting. The company's Chief Movement Officer Arnold Schwarzenegger will take center stage as the conference's Presidential Guest Speaker.
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
20.02.2026 04:04
Over the past six months, Zimmer Biomet’s stock price fell to $99.27. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 7.6%. This might have investors contemplating their next move.
Zimmer Biomet Holdings Inc (ZBH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
12.02.2026 01:04
Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 2025 performance with a 5.4% organic revenue growth and outlines plans for a dedicated US sales channel by 2027.
Zimmer Biomet Q4 Earnings Call Highlights
11.02.2026 07:07
Zimmer Biomet (NYSE:ZBH) reported fourth-quarter 2025 results that management said met its commitments on sales growth, earnings, and free cash flow despite tariff headwinds and the integration of three acquisitions during the year. Executives also outlined a major ongoing shift in the company’s U.S
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook
10.02.2026 17:55
Zimmer’s CEO said its 2026 outlook remains cautious as it focuses on product adoption, a US salesforce transition, and international market performance.